| scholarly article | Q13442814 |
| P356 | DOI | 10.3109/02713688909000044 |
| P698 | PubMed publication ID | 2558849 |
| P2093 | author name string | Easty D | |
| Hill T | |||
| Shimeld C | |||
| Blyth B | |||
| P2860 | cites work | Reactivation of Herpes Simplex Virus Infection by Ultraviolet Light and Possible Involvement of Prostaglandins | Q40033998 |
| Ocular Infection with Herpes Simplex Virus Type 1: Prevention of Acute Herpetic Encephalitis by Systemic Administration of Virus-Specific Antibody | Q40275248 | ||
| Pathogenesis Of Recurrent Herpes Simplex Infections | Q40894382 | ||
| Spread of Virus and Distribution of Latent Infection Following Ocular Herpes Simplex in the Non-immune and Immune Mouse | Q43970840 | ||
| Neutralising antibody in mice with primary and recurrent herpes simplex virus infection | Q44046766 | ||
| Herpes simplex virus--induced destructive corneal disease | Q44111699 | ||
| Ocular infection with herpes simplex virus in nonimmune and immune mice | Q45793921 | ||
| Latency of Herpes Simplex Virus in Absence of Neutralizing Antibody: Model for Reactivation | Q45802978 | ||
| Passive immunization with monoclonal antibodies against herpes simplex virus glycoproteins protects mice against herpetic ocular disease | Q45835141 | ||
| Previous immunization of mice with herpes simplex virus type-1 strain MP protects against secondary corneal infection | Q45836628 | ||
| Protection against herpetic ocular disease by immunotherapy with monoclonal antibodies to herpes simplex virus glycoproteins | Q45841413 | ||
| Spread of herpes simplex virus within ocular nerves of the mouse: demonstration of viral antigen in whole mounts of eye tissue | Q45842200 | ||
| Effect of immunization and immunosuppression on induced ocular shedding and recovery of herpes simplex virus in infected rabbits | Q45842532 | ||
| Quantitation of purified monoclonal antibody needed to prevent HSV-1 induced stromal keratitis in mice. | Q54354126 | ||
| P433 | issue | 11 | |
| P921 | main subject | eye disease | Q3041498 |
| P304 | page(s) | 1193-1205 | |
| P577 | publication date | 1989-11-01 | |
| P1433 | published in | Current Eye Research | Q5195042 |
| P1476 | title | An improved model of recurrent herpetic eye disease in mice | |
| P478 | volume | 8 |
| Q92547226 | CD28 Costimulation Is Required for Development of Herpetic Stromal Keratitis but Does Not Prevent Establishment of Latency |
| Q40967821 | Comparison of herpes simplex virus reactivation in ganglia in vivo and in explants demonstrates quantitative and qualitative differences |
| Q34674612 | Corneal lymphangiogenesis in herpetic stromal keratitis |
| Q36199997 | Decreased reactivation of a herpes simplex virus type 1 (HSV-1) latency-associated transcript (LAT) mutant using the in vivo mouse UV-B model of induced reactivation |
| Q90333633 | IL28B Genetic Variations in Patients with Recurrent Herpes Simplex Keratitis |
| Q35865825 | Mechanisms of herpes simplex virus type 1 reactivation |
| Q37298112 | Non-traumatic acquisition of herpes simplex virus infection through the eye |
| Q27023951 | Pathogenesis of herpes stromal keratitis--a focus on corneal neovascularization |
| Q26823201 | Potential function of miRNAs in herpetic stromal keratitis |
| Q35020742 | Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice |
| Q33652682 | Reactivation of herpes simplex virus type 1 in the mouse trigeminal ganglion: an in vivo study of virus antigen and cytokines. |
| Q36621642 | Recurrent herpetic stromal keratitis in mice, a model for studying human HSK. |
| Q35944884 | Recurrent herpetic stromal keratitis in mice: a model for studying human HSK. |
| Q33558578 | Role of nuclear factor Y in stress-induced activation of the herpes simplex virus type 1 ICP0 promoter |
| Q45723392 | The herpes simplex virus type 1 ICP0 promoter is activated by viral reactivation stimuli in trigeminal ganglia neurons of transgenic mice |
| Q45783001 | The role of nerve growth factor in modulating herpes simplex virus reactivation in vivo |
| Q36124928 | Therapeutic Use of Soluble Fas Ligand Ameliorates Acute and Recurrent Herpetic Stromal Keratitis in Mice |
| Q33851936 | Tracking the spread of a lacZ-tagged herpes simplex virus type 1 between the eye and the nervous system of the mouse: comparison of primary and recurrent infection |
| Q30979930 | Valacyclovir for the prevention of recurrent herpes simplex virus eye disease after excimer laser photokeratectomy |
| Q37201594 | Who (what) pays toll for the development of herpetic stromal keratitis (HSK). |
Search more.